UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 29, 2017
THERMO FISHER SCIENTIFIC INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
1-8002 |
|
04-2209186 |
|
(State or other jurisdiction of |
|
(Commission File Number) |
|
(IRS Employer |
168 Third Avenue
Waltham, Massachusetts 02451
(Address of principal executive offices, including zip code)
(781) 622-1000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging Growth Company. o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 8.01. Other Events.
On August 29, 2017, Thermo Fisher Scientific Inc. (the “Company”) issued a press release announcing the expiration and results of the previously announced tender offer by Thermo Fisher (CN) Luxembourg S.à r.l., a wholly owned subsidiary of the Company, to purchase all of the outstanding ordinary shares of Patheon N.V.
A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release, dated August 29, 2017. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
THERMO FISHER SCIENTIFIC INC. | |
|
|
| |
|
|
| |
|
DATE: August 29, 2017 |
By: |
/s/ Seth H. Hoogasian |
|
|
|
Seth H. Hoogasian |
|
|
|
Senior Vice President and General Counsel |